Onno VAN DE STOLPE
Onno van de Stolpe (CEO) founded Galapagos in 1999 and has grown the Company to its current level of over 800 employees. Galapagos is an integrated drug discovery company with a number of internal programs and two service divisions BioFocus and Argenta. For its internal programs, Galapagos has GSK, J&J, Roche and Servier as alliance partners.
In these programs Galapagos is responsible for delivering clinical molecules after which the partner has certain licensing options. Before Galapagos, Onno established the European operations for Molecular Probes Inc. He started his professional career in 1987 as Manager Business Development at MOGEN, an agricultural biotech company.
Onno received his Master's degree in Virology, with honours, from the Agricultural University in Wageningen, the Netherlands.